Already popular on the online peptide gray market, the new drug, originally developed by Eli Lilly, caused participants in a recent clinical study to lose more than a quarter of their body weight over 80 weeks at the highest doseresults comparable to bariatric surgery
CJC-1295 No DAC (5mg) + Ipamorelin (5mg) research bundle
Other medical conditions, like kidney disease , liver disease , or certain digestive disorders
GIP Receptor GIP is glucose-dependent insulinotropic polypeptide
By stimulating endogenous growthhormone release, supporting melatonin production, and tempering nighttime cortisol spikes, these peptides deepen slowwave sleep, enhance recovery, and stabilize overall endocrine balance